OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells presents a paramount challenge with the biopharmaceutical industry. Various strategies can be employed maximize antibody titer, such as process parameter optimization, cell line development, and the use of perfusion technologies. Fine-tuning growth parame